In the recent years, Kingston has become a primary destination for health-tech startups and sustainable chemical manufacturers. With a municipal focus on creating a fully integrated and collaborative community, local businesses are perfectly positioned to leverage programs that reward clinical R&D and advanced manufacturing. We align your growth objectives with the mandates that prioritize Kingston’s regional leadership in the life sciences.
Health Innovation Pathway & Clinical Grants
For Kingston’s thriving life sciences sector, the Health Innovation Pathway is the primary vehicle for bringing medical technologies to market. We target the Health Technology Accelerator Fund to help you generate the evidence needed for provincial adoption. We specialize in navigating the complex regulatory and clinical requirements, helping you secure funding for medical devices, digital health solutions, and tissue engineering projects that have achieved TRL 8 or higher.
SR&ED Tax Credit (The Research Baseline)
Kingston is a city of researchers. The SR&ED tax credit remains the foundation for your innovation, allowing Canadian-controlled private corporations to recover up to 35% of qualified expenditures. Whether you are solving technological uncertainties in human mobility at the Human Mobility Research Hub or developing novel bioprocesses for regenerative medicine, we translate your technical trials into predictable cash flow.
FedDev Ontario: Business Scale-Up & Productivity
For Kingston’s “Sustainable Manufacturing” cluster, including firms in EV battery tech and rare earth element recycling, FedDev Ontario provides the heavy-duty scaling capital required for global expansion. This year, the program prioritizes projects that integrate AI and quantum computing into manufacturing. We help you secure repayable contributions starting at $500,000 for facility modernizations and high-performance equipment that drive Kingston’s net-zero transition.
Life Sciences Innovation Fund (LSIF)
Targeting early-stage risk capital, the LSIF provides up to $500,000 for companies to scale made-in-Ontario health solutions. We help Kingston-based startups (often emerging from the Queen’s University ecosystem) position their medical innovations for this early-stage investment, ensuring you have the runway to navigate clinical trials and initial market entry.
